COMPANY
Message
At Cerustar, we utilize leading-edge life sciences technology to provide patients with new forms of value that “enriches their lives.”
Nowadays, “objects” are not the only means of treating the living body. Recent research has shown that “cells” are also a viable option and they are now being put to practical use.
At Cerustar, we are conducting joint research with the Singaporean Agency for Science, Technology and Research (A*STAR), aiming to discover new technologies and insights, apply them to the life sciences, and contribute to society at large.
Shigeo Murakami
President and Representative Director
Corporate profile
| Company name | Cerustar PTE. LTD |
|---|---|
| Address | 150 Kampong Ampat, #04-08 KA Centre, Singapore 368324 Telephone: +65 6334 8568 Email: info@Cerustar.com |
| Date established | January 9, 2019 |
| Scope of business | Regenerative medicine business |
| Representative | Shigeo Murakami |
| Capital | SGD 650,080（as of June 1, 2023） |
History
Mar. 2023 Subsidiary Cellastar Co., Ltd. established in Japan Oct. 2019 Joint research on efficient methods for the culture of adipose-derived cells commenced with the Agency for Science, Technology and Research (A*STAR) Jan. 2019 Cerustar PTE. LTD established in Singapore and regenerative medicine business launched 